Global Market OverviewThe Global Tissue Diagnostics Market is projected to grow at a CAGR of 7% by 2026. The market expansion is driven by the increasing prevalence of cancer and neoplastic diseases, ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint ...

Inside every human cell, a quiet surveillance network is constantly scanning for trouble, sounding molecular alarms long ...

Extracellular vesicles (EVs) have rapidly emerged as one of the most promising frontiers in modern biology. These nano-sized messengers mediate ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistan ...

November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...

WHO releases first global guideline on GLP-1 therapies for obesity treatment Obesity now affects over 1 billion people worldwide, driving millions of ...

Report AttributeDetailsHistorical Period2020-2023Base Year2024Forecast Period2026-2032Market Size 2024USD 3,474.79 MillionCAGR (2026-2032)28.53 %Market ...

The race to build the world’s most efficient solar cell is no longer a theoretical contest inside physics labs, it is a ...

Reductions in airway hyperresponsiveness and suppressed eosinophilic response at both 6 weeks and 12 weeks observed after a ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

From the fufu bowls to the fruits on our tables, danger lurks in what we eat, making every meal a potential threat to life.